Product Information
ATOVAQUONE 750 MG/5 ML SUSP CUP is a generic product labeled by Major Pharmaceuticals, priced at $0.7668 per ML under NDC 00904745953. Its NADAC has been published 102 times since Oct 23, 2024.
FDA first approved this application on Oct 25, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/5mL
Manufacturer
Major PharmaceuticalsNDC
00904745953
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA214272FDA Approved
10/25/2021
TE Code
AB
On Market Since
7/8/2024
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP CUP has been published 102 times since Oct 23, 2024, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7668 per ML |
|---|---|
| All-time high | $0.9555 (Nov 13, 2024) |
| All-time low | $0.6842 (Jul 22, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6842 |
| Median price | $0.8276 |
| Average price | $0.7946 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 102 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Atovaquone Oral Suspension market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atovaquone Oral Suspension market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP CUP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP CUP, manufactured by Major Pharmaceuticals, is $0.7668 per ML (NDC 00904745953), effective Sep 30, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP CUP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP CUP has declined 19.7%. It has been tracked across 102 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP CUP?
Since Oct 23, 2024, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP CUP has ranged from a low of $0.6842 (Jul 22, 2026) to a high of $0.9555 (Nov 13, 2024), with a median of $0.8276 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP CUP?
No other NADAC-published product currently shares the active ingredient and strength of ATOVAQUONE 750 MG/5 ML SUSP CUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP CUP?
ATOVAQUONE 750 MG/5 ML SUSP CUP (NDC 00904745953) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.